A term sheet summarizes the principal terms of a proposed financing - valuation, amount, security type, board composition, liquidation preference, anti-dilution, protective provisions - before counsel drafts definitive documents. Most terms are non-binding, but clauses such as confidentiality, exclusivity (a no-shop period, often 30 to 60 days) and governing law are usually binding. Economic terms set what investors get, and control terms set who decides. Many US deals use the NVCA model documents as a starting point, which speeds up legal drafting.

Why it matters

In MedTech, term sheets often include milestone-based tranches tied to regulatory or clinical events (e.g., Tranche 2 releases on IDE approval). Founders should focus as much on control terms (board, protective provisions) as on valuation.

Common pitfalls

•Optimizing only for valuation and ignoring liquidation preferences, participation, or protective provisions.
•Signing exclusivity (no-shop) without a clear timeline.

Sources

NVCA Model Term Sheet · NVCA
Silicon Valley Bank - Healthcare Reports · SVB
PitchBook - MedTech Coverage · PitchBook
EIC Fund investment process: term sheet and approval · European Innovation Council

Open full page

Select term B to compare.

Why compare MedTech terms side by side?

MedTech terminology is full of pairs that look interchangeable but carry very different regulatory, clinical, and commercial consequences. Picking the wrong framework, pathway, or standard early in a project can add months to a submission, invalidate clinical evidence, or trigger an audit finding. Side-by-side comparison is the fastest way to surface those differences before they become costly mistakes.

Each comparison on this page pulls from the same vendor-neutral, sourced definitions used throughout the MedTech Terms glossary. You see the one-line summary, the formal definition, why it matters in practice, common pitfalls, and the primary sources (FDA guidance, EU MDR/IVDR articles, ISO/IEC standards, MDCG documents, IMDRF principles) that back each entry. That makes the comparison defensible in regulatory strategy memos, design reviews, and submission narratives.

Common comparison patterns

Regulatory pathway choice - 510(k) vs PMA, 510(k) vs De Novo, Abbreviated vs Special 510(k).
Quality systems - QSR vs ISO 13485, QMSR vs QSR.
Software classification - SaMD vs SiMD, Locked vs adaptive AI.
EU frameworks - MDR vs IVDR, CE Mark vs UKCA.
Cybersecurity artifacts - SPDX vs CycloneDX SBOM, CVE vs CVSS.
Post-market actions - Recall vs field action, Removal vs correction.

How to use this tool

Pick term A and term B from the dropdowns, or click a preset above. The URL updates with both slugs so you can bookmark or share the exact comparison with a colleague, a notified body reviewer, or your regulatory consultant. Click Open full page on either side for the complete entry, including FAQs, related terms, and the full citation list. If you are not sure which term to start with, browse the Categories view or the A-Z index.

MedTech Terms is a vendor-neutral community resource sponsored by Blue Goat Cyber. Definitions are written for educational use and are not legal or regulatory advice.